Point tools give you data.
BioAlma gives you decisions.
The Medical & Business intelligence platform for biotech — two functions, nine modules, one source of truth. Type a company name to see a live snapshot, free.
Nine modules. One login. One source of truth.
Medical Affairs and Business Development share one data model — a signal in one module updates the others, so every team works from the same continuously updated picture.
Intelligence briefs
Source-verified competitive intelligence across the gene, cell, and T-cell-engager landscape.
The intelligence behind every MA & BD call
Synthesis is the product — BioAlma connects public, congress, client, and acquired data into one decision-ready view.
Synthesis is the product
BioAlma connects public, congress, client, and acquired data into one decision-ready view. Model competitive launches, market sizing, and risk on a visual canvas — every assumption structured, sourced, auditable, and ready for your board.
- ✓ Public, congress, client, and acquired data in one view
- ✓ Assumptions structured and traceable to sources
- ✓ Shareable canvases for board and partner prep
- ✓ What-if modeling with instant recalculation
Your market, mapped
See where the market actually is. KOLs, treatment sites, and infusion centers in one geographic view — with patient distributions, referral patterns, and account segmentation layered on the same map your field teams plan against.
- ✓ Infusion centers, treatment sites & KOLs on one US map
- ✓ Patient & claims distributions by geography
- ✓ Account segmentation and territory whitespace
- ✓ The same provider intelligence powering the dashboard
Built by someone who's been in your shoes
Daniel is a neuroscientist and biotech executive with 20 years of experience in venture building — across the US and Brazil, from pre-clinical startups to public pharma. He has sat in your seat: needing a sharp read on the competitive landscape, quickly, without a six-figure platform contract.
That is the real difference here. The big intelligence vendors sell you a platform and leave you alone with it — no one to call, no one to ask “can you cut this another way?” With BioAlma, Daniel personally crafts your intelligence boards — and he is on the other end: to talk through what the data means, refine a view, or run a brand-new analysis the moment your questions change.
“The big platforms give you software. I give you the analysis — and a real person to ask when you need it cut another way.”
One platform for Medical Affairs and BD.
Nine modules on one source of truth — cloud or on-prem, with strict tenant isolation, so your protected data never powers a competitor's view.
Book a demo